Drug intelligence / Profile preview

Nankang Tablets

Development stage: Unknown
Lead developer: Shanxi Wanglong Pharmaceutical Group
Modality: Small Molecules
Administration: Oral

Overview

Nankang Tablets (男康片) is an approved traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Shanxi Wanglong Pharmaceutical Group. It is administered as an oral tablet and is indicated for the symptomatic treatment of urinary disorders and various men's health conditions. As a traditional multi-herb formulation, its mechanism of action is based on holistic TCM principles rather than specific, disclosed molecular targets. The product is part of Shanxi Wanglong's portfolio of marketed TCM products in China, representing a traditional approach to urological health.

Brand names: 男康片Nankang Pian
Other names: Nankang Tablets

Beyond the preview

Go deeper on Nankang Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nankang Tablets.

Explore the full profile